During the past decade, University of Rochester, Department of Neurology conducted 1 clinical trials. In the 10-year time frame, 1 clinical trials started and 1 clinical trials were completed, i.e. on average, 100% percent of trials that started reached the finish line to date. In the past 5 years, 0 clinical trials started and 0 clinical trials were completed. i.e. 0% of trials that started reached the finish line.

Out of the total clinical trials conducted in "University of Rochester, Department of Neurology" #1 sponsor was "University of Rochester" with 2 trials, followed by "Cephalon" with 1 trials sponsored, "Sarepta Therapeutics, Inc." with 1 trials sponsored, "University of California, Los Angeles" with 1 trials sponsored and "University of Cincinnati" with 1 trials sponsored. Other sponsors include -5 different institutions and companies that sponsored additional 5 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "University of Rochester, Department of Neurology" #1 collaborator was "National Institute of Neurological Disorders and Stroke (NINDS)" with 2 trials as a collaborator, "H. Lundbeck A/S" with 1 trials as a collaborator and "The Parkinson Study Group" with 1 trials as a collaborator. Other collaborators include -3 different institutions and companies that were collaborators in the rest 3 trials.

According to Clinical.Site data, the most researched conditions in "University of Rochester, Department of Neurology" are "Myotonic Dystrophy" (2 trials), "Attention Deficit Disorder With Hyperactivity" (1 trials), "Congenital Myotonic Dystrophy" (1 trials), "Duchenne Muscular Dystrophy" (1 trials) and "Epilepsy" (1 trials). Many other conditions were trialed in "University of Rochester, Department of Neurology" in a lesser frequency.

Most popular intervention types in "University of Rochester, Department of Neurology" are "Drug" (5 trials), "Other" (2 trials) and "Procedure" (1 trials). Other intervention types were less common.

The name of intervention was led by "CEP-1347 10mg" (1 trials), "CEP-1347 50mg" (1 trials), "CEP1347 25mg" (1 trials), "Casimersen" (1 trials) and "Golodirsen" (1 trials). Other intervention names were less common.

The vast majority of trials in "University of Rochester, Department of Neurology" are 5 trials for "All" genders and 1 trials for "Male" genders.

Currently, there are NaN active trials in "University of Rochester, Department of Neurology". undefined are not yet recruiting, 1 are recruiting, undefined are Active, not recruiting, and 1 are Enrolling by invitation. In total, there were 3 completed trials in University of Rochester, Department of Neurology, undefined suspended trials, and 1 terminated clinical trials to date.

Out of the total trials that were conducted in University of Rochester, Department of Neurology, 0 "Phase 1" clinical trials were conducted, 2 "Phase 2" clinical trials and 4 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 0 trials that are defined as “Not Applicable".